Sultan Y
About
In The Last Decade
Sultan Y
61 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 87
- Hematology 918
- Rheumatology 286
- Genetics 238
- Pulmonary and Respiratory Medicine 138
- Surgery 127
Countries citing papers authored by Sultan Y
This map shows the geographic impact of Sultan Y's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sultan Y with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sultan Y more than expected).
Fields of papers citing papers by Sultan Y
This network shows the impact of papers produced by Sultan Y. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sultan Y. The network helps show where Sultan Y may publish in the future.
Co-authorship network of co-authors of Sultan Y
This figure shows the co-authorship network connecting the top 25 collaborators of Sultan Y. A scholar is included among the top collaborators of Sultan Y based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sultan Y. Sultan Y is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 23 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | Multicenter comparison of inhibitor (Inh) development on plasma-derived (PD) vs recombinant (rec) factor VIII(fVIII) in severe hemophilia a patients (sHA pts) | 2 |
| 6 | Nonsurgical synovectomy in the treatment of arthropathy in Von Willebrand's Disease. | 3 |
| 7 | 7 | |
| 8 | 1 | |
| 9 | 12 | |
| 10 | 6 | |
| 11 | Epidemiology of HIV infection in multitransfused hemophilic patients in France. French Study Group in Hemophilia. | 2 |
| 12 | 2 | |
| 13 | [Epidemiology of infection by LAV/HTLV-III virus in hemophiliacs multitransfused in France. Results of a survey conducted by 28 hemophilia centers]. | 1 |
| 14 | Epidémiologie de l'infection par le virus LAV/HTLVIII chez les hémophiles polytransfusés en France. Résultats d'une enquête menée par 28 centres d'hémophiles. | 2 |
| 15 | Hemophilic patients with an inhibitor to factor VIII treated with high dose factor VIII concentrate. Results of a collaborative study for the evaluation of factor VIII inhibitor titer, recovery and half life of infused factor VIII. | 7 |
| 16 | 11 | |
| 17 | The suppression of factor VIII antibodies in haemophilia. | 13 |
| 18 | [Quantitative study of bleeding time and platelet function during thrombopenic purpura]. | 1 |
| 19 | [Anomalies of platelet in the syndrome of radial aplasia with thrombocytopenia]. | 1 |
| 20 | [Acquired blood platelet disorders]. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.